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o investigate the requirement for pRb in myogenic
differentiation, a ﬂoxed 
 
Rb
 
 allele was deleted either
in proliferating myoblasts or after differentiation. 
 
Myf5-
Cre
 
 mice, lacking pRb in myoblasts, died immediately at
birth and exhibited high numbers of apoptotic nuclei
and an almost complete absence of myoﬁbers. In contrast,
 
MCK-Cre
 
 mice, lacking pRb in differentiated ﬁbers, were
viable and exhibited a normal muscle phenotype and ability
to regenerate. Induction of differentiation of Rb-deﬁcient
primary myoblasts resulted in high rates of apoptosis and a
total inability to form multinucleated myotubes. Upon
T
 
induction of differentiation, Rb-deﬁcient myoblasts up-reg-
ulated myogenin, an immediate early marker of differentia-
tion, but failed to down-regulate Pax7 and exhibited growth
in low serum conditions. Primary myoblasts in which 
 
Rb
 
was deleted after expression of differentiated 
 
MCK-Cre
 
formed normal multinucleated myotubes that did not enter
S-phase in response to serum stimulation. Therefore, Rb
plays a crucial role in the switch from proliferation to dif-
ferentiation rather than maintenance of the terminally dif-
ferentiated state.
 
Introduction
 
The development of skeletal muscle in mammals provides a
powerful system with which to study the molecular regulation
of genesis, growth, and differentiation of stem cells during
embryonic and regenerative myogenesis (Parker et al., 2003).
Importantly, the activity of the bHLH transcription factor
family of myogenic regulatory factors (MRFs) is tightly
coupled to cell cycle control, and the study of this regulation
has provided important insights into the cellular mechanisms
that regulate cell growth versus differentiation or apoptosis
(Walsh and Perlman, 1997; Yee et al., 1998; Puri and
Sartorelli, 2000).
MRFs are subject to regulation that acts to couple MRF
activity to the cell cycle. Hypophosphorylated pRb was
suggested to bind MyoD and this association to be required
for MyoD-mediated activation of E-box–containing muscle-
specific promoters (Gu et al., 1993). However, direct binding
between pRb and MyoD has been ruled out by in vivo and
in vitro assays (Zhang et al., 1999a,b). Therefore, pRb likely
potentiates MyoD activity via an indirect mechanism not
involving binding Rb to MyoD.
Proliferating myoblasts express Id, activated Cdk4, low
levels of hyperphosphorylated Rb, and free E2Fs as well as
E2Fs complexed largely with p107. Activated Cdks and Id
both stimulate cell cycle progression. In contrast, myotubes
express high levels of p21 and hypophosphorylated pRb.
Despite the abundance of hypophosphorylated pRb, p130–
E2F4 complexes are the predominant E2F complexes in the
myotube (Corbeil et al., 1995). Terminal differentiation and
protection against apoptosis is maintained by Cdk inhibitors
(p21, p27, etc.) and high expression of hypophosphorylated
pRb (Jiang et al., 2000; Peschiaroli et al., 2002; Ho et al.,
2004). Together, these data suggest that during myogenic
differentiation pRb plays a role distinct from the conven-
tional repression of E2F transcriptional activity.
Newborn mice lacking pRb exhibit multiple deficits includ-
ing severe deficiencies in the formation of skeletal muscle
(Zacksenhaus et al., 1996; de Bruin et al., 2003; Wu et al.,
2003). Studies using MyoD-converted pRb-deficient em-
bryonic fibroblasts have suggested that 
 
Rb
 
 is essential for
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both MyoD and MEF2 transcriptional activity, as well as
maintaining the terminally differentiated state (Schneider
et al., 1994; Novitch et al., 1996, 1999). Although pRb-
deficient fibroblasts transfected with MyoD become myo-
genic and express early muscle markers such as myogenin,
expression of late markers such as myosin heavy chain
(MHC) is reduced. In addition, serum restimulation of
these differentiated pRb-deficient myoblasts results in
BrdU incorporation and, thus, S-phase entry and DNA
synthesis. However, these cells are unable to enter mitosis.
Moreover, forced expression of MyoD in a variety of 
 
Rb
 
 
 
/
 
 
 
fibroblastic cells results in apoptosis that appears to be p21
dependent (Peschiaroli et al., 2002). In the absence of
N-
 
ras
 
, pRb-deficient embryos exhibit normal muscle differ-
entiation without apoptosis, suggesting a role for signaling
downstream of N-
 
ras
 
 in provoking cell death in 
 
Rb
 
 
 
/
 
 
 
 mus-
cle (Takahashi et al., 2003).
Rb plays a key role in controlling cell cycle progression
through the G1 restriction point for entry into S-phase
(Stevaux and Dyson, 2002). During myogenic differentia-
tion, proliferating myoblasts must also exit the cell cycle
from the G1 phase, before the restriction point (Perry and
Rudnick, 2000). Therefore, it can be hypothesized that pRb
plays an analogous role in myoblasts by regulating the switch
from proliferation to differentiation.
To investigate the requirement for pRb in myogenic dif-
ferentiation, we examined the proliferation and differentia-
tion potential of primary myoblasts in which a floxed 
 
Rb
 
 al-
lele was deleted either before or after differentiation. Our
experiments unequivocally establish that pRb is required for
progression of the differentiation program and not for main-
tenance of the differentiated state.
 
Results
 
Rb
 
f/f
 
:Myf5-Cre
 
 mice die at birth with severe 
muscle deficits
 
To investigate the requirement for pRb in myogenesis,
mice carrying a floxed 
 
Rb
 
 allele (Marino et al., 2000) were
interbred with 
 
Myf5-Cre
 
 knockin mice (Tallquist et al.,
2000) or 
 
MCK-Cre
 
 transgenic mice (Wang et al., 1999).
The 
 
Myf5-Cre
 
 allele faithfully recapitulates the expression
pattern of the endogenous 
 
Myf5
 
 gene and is uniformly
expressed in all proliferating myoblasts (Tallquist et al.,
2000). In contrast, the 
 
MCK-Cre
 
 transgene is not expressed
in myoblasts but is up-regulated in differentiated multinu-
cleated skeletal myotubes (Wang et al., 1999; Andrechek et
al., 2002).
 
Rb
 
f/f
 
 males were crossed with 
 
Rb
 
f/wt
 
:Myf5-Cre
 
 females to
generate 
 
Rb
 
f/f
 
:Myf5-Cre
 
 progeny. Notably, no viable 
 
Rb
 
f/f
 
:
Myf5-Cre
 
 mice were identified after genotyping over 95 off-
spring. Examination of newborn litters revealed the expected
Mendelian proportion of 
 
Rb
 
f/f
 
:Myf5-Cre
 
 pups. However, the
newborn pups lacking pRb in myoblasts were motionless,
became cyanotic, and failed to survive. Therefore, we con-
cluded that 
 
Rb
 
f/f
 
:Myf5-Cre
 
 mice exhibited a phenotype simi-
Figure 1. Severely impaired myogenesis in P0 Rb
f/f:Myf5-
Cre mice. Hematoxylin and eosin staining of paraffin-
embedded longitudinal sections through the hind limb 
of control (A and C) and Rb
f/f:Myf5-Cre (B and D) mice. 
Hematoxylin and eosin staining of cross sections through 
diaphragm of control (E) and Rb
f/f:Myf5-Cre (F) mice. 
Bars: (A and B) 400  m; (C–F) 50  m. 
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lar to that of other 
 
Rb
 
 knockout mouse models (Lasorella et
al., 2000; de Bruin et al., 2003).
Histological examination of skeletal muscle revealed the
presence of severe differentiation deficits (Fig. 1, A–F). Hind
limb muscles exhibited a dramatic reduction in mass with a
complete absence of mature fibers compared with littermate
controls (
 
n
 
 
 
  
 
3 independent animals; Fig. 1, compare A
with B). In addition, the morphology of the residual muscle
fibers in the 
 
Rb
 
f/f
 
:Myf5-Cre
 
 mice was short and irregular in
shape (Fig. 1 D). Moreover, the long and orderly parallel ar-
rangement of the fibers typically seen in the wild-type con-
trols was absent in the 
 
Rb
 
f/f
 
:Myf5-Cre
 
 muscle (Fig. 1, com-
pare C with D). These results confirm the well-established
requirement for pRb in myogenesis.
The severe deficit in muscle tissue development led us to
question whether the residual muscle fibers were undergoing
appropriate differentiation. Therefore, immunofluorescent
staining of the MHC terminal differentiation marker, and of
desmin—a marker for myoblasts and newly formed fibers—
was performed (Fig. 2, A–H). Desmin expression was signif-
icantly diminished in both hind limb and intercostal mus-
cles in the 
 
Rb
 
f/f
 
:Myf5-Cre
 
 mice in comparison with the level
of staining in the control sections (
 
n
 
 
 
  
 
3 independent ani-
mals; Fig. 2, compare A and C with E and G). Interestingly,
MHC expression was considerably diminished in limb mus-
culature, but was less affected in intercostal muscles (Fig. 2,
F and H). Together, the histological and immunofluores-
cent analyses support the notion that 
 
Rb
 
f/f
 
:Myf5-Cre
 
 pups die
at birth due to severe deficiencies in skeletal muscle that im-
pede ventilation, leading to rapid cyanosis and death.
 
Rb
 
f/f
 
:MCK-Cre
 
 mice are viable and apparently normal
 
Genetic crosses between 
 
Rb
 
f/wt
 
 and 
 
Rb
 
f/wt
 
:MCK-Cre
 
 mice re-
sulted in completely viable and healthy 
 
Rb
 
f/f
 
:MCK-Cre
 
 mice
in the expected Mendelian ratio. 
 
Rb
 
f/f
 
:MCK-Cre
 
 mice were
similar in size to wild-type littermates, from birth to late
adulthood, and appeared normal in all respects. Skeletal
muscle–specific expression of the 
 
MCK-Cre
 
 transgene was
tested by crossing 
 
MCK-Cre
 
 mice with the 
 
R26R3
 
 Cre–
inducible LacZ reporter line of mice. Single fibers isolated
from 
 
R26R3:MCK-Cre
 
 mice displayed robust X-Gal stain-
ing, confirming the proper expression of the 
 
MCK-Cre
 
 trans-
gene (Fig. 3 H). To quantitatively assess the efficiency of
 
Rb
 
 gene deletion in 
 
Rb
 
f/f
 
:MCK-Cre
 
 mice, we calculated
the 
 
Rb
 
flox
 
:Rb
 
excised
 
 allele ratios using densitometry. These al-
lele ratios were used to determine the percentage of the un-
excised 
 
Rb
 
flox
 
 allele in pooled single muscle fiber prepa-
rations (
 
n
 
 
 
  
 
3 independent animals). As expected, we
detected low levels of the unexcised 
 
Rb
 
flox
 
 allele; this result is
likely due to the presence of satellite cells on the muscle fi-
bers (
 
 
 
1–2% 
 
Rb
 
flox
 
 remaining in 
 
Rb
 
f/f
 
:MCK-Cre
 
 fibers; Fig.
3 I). Additionally, protein levels of pRb were examined by
Western blot analysis of pooled single fibers from 
 
Rb
 
f/f
 
:
MCK-Cre
 
 and 
 
Rb
 
f/wt
 
 littermate controls (200 fibers per ani-
mal). Levels of pRb were readily detectable in the control fi-
bers but were below the limit of detection in the 
 
Rb
 
f/f
 
:MCK-
Cre
 
 fibers (Fig. 3 J). The extremely low levels of pRb in the
 
Rb
 
f/f
 
:MCK-Cre
 
 fibers precluded any possibility of compar-
ing fold differences by this method. Our histological analy-
sis of the hind limb skeletal muscle revealed no gross abnor-
malities in the skeletal muscle fibers of 
 
Rb
 
f/f
 
:MCK-Cre
 
 mice
in comparison with littermate controls (
 
n
 
 
 
  
 
3 independent
animals; Fig. 3, compare A–C with D–F). The fiber calibers
of 
 
Rb
 
f/f
 
:MCK-Cre
 
 and littermate controls (
 
n
 
 
 
  
 
3) were on
average similar (unpublished data). The normal appearance
of the skeletal muscle phenotype prompted us to examine
the regenerative capacity of the 
 
Rb
 
f/f
 
:MCK-Cre
 
 skeletal mus-
cle using cobra venom–derived cardiotoxin. After cardio-
toxin-induced injury to the tibialis anterior muscle, 
 
Rb
 
f/f
 
:
MCK-Cre
 
 mice demonstrated no deficit in the regeneration
of the damaged muscle tissue (
 
n
 
 
 
  
 
3 independent animals;
unpublished data). Together, these data suggest that pRb is
not required for the maintenance or regeneration of differ-
entiated skeletal muscle.
Figure 2. Abnormal skeletal muscle differentiation in P0 Rb
f/f:Myf5-Cre mice. Immunofluorescent staining of longitudinal sections through 
the hind limb of control (A and B) and Rb
f/f:Myf5-Cre (E and F) mice with antibodies to desmin and myosin heavy chain (MHC). Immuno-
fluorescent staining of intercostal muscles of control (C and D) and Rb
f/f:Myf5-Cre (G and H) mice with antibodies to desmin and MHC. 
Bars: (A, B, E, and F) 50  m; (C, D, G, and H) 100  m.868 The Journal of Cell Biology | Volume 166, Number 6, 2004
Rb-deficient primary myoblasts exhibit altered cell 
cycle kinetics
To investigate the cellular basis for the muscle deficits in
newborn Rb
f/f:Myf5-Cre mice, we isolated primary myoblasts
from Rb
f/f adult muscle. To generate null mutations in Rb,
we infected primary myoblasts isolated from Rb
f/f mice with
Cre-expressing adenovirus (Ad-Cre; Anton and Graham,
1995). Myoblasts were infected with Lac-Z–expressing ade-
novirus (Ad-Lac-Z) as a control.
Adenoviral infection and expression of Cre resulted in
the complete excision of the floxed region of Rb as assessed
by 
32P end-labeled PCR genotyping and Western blot anal-
ysis (Fig. 4, A and B). Our method of 
32P end-labeled PCR
genotyping was capable of detecting an Rb
flox:Rb
excised allele
ratio as low as 10
 4 when amplified from 20 ng of total
DNA (unpublished data). Moreover, pRb protein was be-
low the level of detection by Western blot analysis in Ad-
Cre–infected Rb
f/f myoblasts (n   3 independent isolates
and more than three infections per isolate). Additionally,
pRb protein was undetectable by immunofluorescence in
the nuclei of the Ad-Cre–infected myoblasts after 2 d in
differentiation media (DM), when pRb is normally ex-
pressed at high levels (n   3; Fig. 4 C). Ad-Cre–infected
myoblasts appeared to be smaller and more compact than
the control-infected cells. Our visual assessment was vali-
dated by flow cytometry analysis that confirmed the actual
decrease in average size of pRb-deficient myoblasts relative
to controls (unpublished data).
Cells with null mutations in Rb display altered cell cycle
kinetics consistent with the role for pRb as an important
G1/S checkpoint regulator (Herrera et al., 1996; Classon et
al., 2000). Therefore, we examined the growth characteris-
tics of pRb-deficient primary myoblasts. We observed in-
creased growth kinetics with a 2.5-fold decrease in the aver-
age doubling time (n   6). The myoblasts exhibited a 17%
reduction in the G0/G1 population ( 60% compared with
 50% for control and Rb
f/f:Ad-Cre, respectively) and a 30%
increase in S-phase populations ( 20% compared with
 30% for control and Rb
f/f:Ad-Cre, respectively) of an asyn-
chronously dividing pool of cells. Despite the compact
morphology and altered cell cycle characteristics, pRb null
primary myoblasts under subconfluent growth conditions
showed no obvious evidence of senescence or cell death after
a high number of passages (n   3,  15 passages). Together,
these data indicate that pRb-deficient myoblasts exhibit a
relatively subtle phenotype associated with an enhanced pro-
liferative potential. Therefore, these data suggest that the
perinatal death of pups was not due to proliferation deficien-
cies of the myogenic progenitors.
Rb-deficient primary myoblasts are incapable 
of differentiation
Primary myoblasts can be quickly and efficiently induced to
exit the cell cycle and initiate the differentiation program by
exposure to low serum conditions. To investigate the differ-
entiation potential of primary myoblasts lacking pRb, we ex-
Figure 3. Rb
f/f:MCK-Cre mice have normal skeletal 
muscle. Hematoxylin and eosin staining of frozen 
cross sections of control muscles (A–C) and Rb
f/f:
MCK-Cre muscles (D–F). TA, tibialis anterior; EDL, 
extensor digitorum longus. Phase-contrast micro-
graph of X-Gal–stained single muscle fibers of 
R26R3 control (G) and R26R3:MCK-Cre (H) mice. 
(I) 
32P end-labeled PCR genotype analysis of the 
floxed Rb locus revealed 98–99% excision. 
32P 
end-labeled PCR was performed on DNA samples 
extracted from a pool of 20 single fibers from three 
independent mice (Rb
f/f:MCK-Cre A, Rb
f/f:MCK-
Cre B, and Rb
f/f:MCK-Cre C). (J) pRb immunoblot 
analysis of single-fiber protein extracts reveals 
virtually no detectable pRb.  -Tubulin protein 
levels were used as loading controls. Protein was 
extracted from a pool of 200 single fibers from 
Rb
f/f:MCK-Cre A and Rb
f/f:MCK-Cre B mice, and 
from Rb
f/wt A and Rb
f/wt B littermate controls. Protein 
extracts from Ad-Lac-Z– and Ad-Cre–infected 
Rb
f/f primary myoblasts were used as positive and 
negative controls, respectively. Bars, 50  m.Rb is not required for maintenance of differentiation | Huh et al. 869
posed Ad-Cre–infected Rb
f/f myoblasts to low serum condi-
tions using standard procedures (Sabourin et al., 1999). We
observed a rapid loss of cell viability (Fig. 5) together with
an inability of the remaining cells to form multinucleated
myotubes (see Fig. 6, compare C with F).
Detection of nuclear fragmentation by TUNEL revealed
apoptotic nuclei beginning to accumulate 6 h after serum re-
duction (Fig. 5, A–F). TUNEL staining was detected in a
markedly higher number of pRb-deficient myoblasts by 6 h
in low serum media (6.7   2.4% compared with 22.3  
1.52% for control and Rb
f/f:Ad-Cre, respectively). The ele-
vated levels of apoptosis gradually diminished the total cell
numbers in direct relation to the length of time spent under
low serum conditions (n   3 independent isolations and in-
fections;  25% compared with  85% cell death in controls
and Rb
f/f:Ad-Cre, respectively, after 5 d in low serum).
Interestingly, the small number of cells that did survive
the low serum conditions appeared incapable of differentia-
tion. The surviving pRb-deficient primary cells were adher-
ent and formed elongated mononuclear myocytes that failed
to fuse with closely neighboring myocytes to form multinu-
cleated myotubes (Fig. 4 C, bottom left).
We conducted immunofluorescent staining experiments
to examine the cellular expression and localization patterns
of MyoD, myogenin, and MHC (n   3 independent isola-
tions and infections; Fig. 6, A–L). MyoD is expressed in
proliferating myoblasts and is down-regulated during differ-
entiation. Myogenin is not expressed in proliferating myo-
blasts and is up-regulated in mononuclear cells as an early re-
sponse gene during induction of differentiation. Finally,
MHC is up-regulated relatively late in the differentiation
program and is typically detected in multinucleated myo-
tubes (Sabourin et al., 1999).
Under growth conditions, MyoD was localized to the nu-
clear compartment and similarly expressed in almost all of
the pRb-deficient and wild-type primary myoblasts (Fig. 6,
A and D). In addition, high levels of MyoD were detected in
the nuclei of the pRb-deficient and wild-type myoblasts by
day 1 of differentiation (Fig. 6, B and E). After differentia-
tion, MyoD protein was down-regulated to low levels in vir-
tually all the nuclei of wild-type multinucleated myotubes
(Fig. 6 C). In contrast,  36% of the pRb-deficient Rb
f/f:Ad-
Cre myocytes continued to express high levels of MyoD
(Fig. 6 F). Western blot analysis showed that both wild-type
and mutant myoblasts expressed similar levels of MyoD in
subconfluent growth conditions (Fig. 7 C). However, by
days 3 and 5 of differentiation, mutant cells had failed to
down-regulate MyoD (n   3; Fig. 7 C).
Myogenin was expressed at typically low levels in subcon-
fluent cultures of wild-type and Rb mutant primary myo-
blasts. Up-regulation of myogenin expression occurred after
1 d of differentiation in both wild-type and pRb-deficient
cells to about equal levels (Fig. 6, G, H, J, and K). However,
by day 5 of differentiation, myogenin protein was detectable
in only 17% of wild-type nuclei, whereas  50% of Rb-defi-
cient cells exhibited robust nuclear expression (Fig. 6, I and
L). Western blot analysis revealed that myogenin was not de-
tectable in either wild-type or mutant myoblasts in growth
conditions (Fig. 7 C). However, by days 3 and 5 of differen-
tiation, mutant cells had failed to down-regulate myogenin
(n   3; Fig. 7 C). Therefore, pRb-deficient myoblasts en-
tered the differentiation program, as evidenced by the up-
regulation of myogenin, which is an immediate early marker
of commitment for differentiation (Bergstrom et al., 2002).
After 1 d of differentiation, cytoplasmic MHC expression
was detected by immunofluorescence in newly formed wild-
type myotubes, whereas little such expression was detected
in mutant cells (Fig. 6, compare B with E). By day 5 of dif-
ferentiation, robust cytoplasmic MHC staining was evident
Figure 4. Adenoviral delivery of Cre recombinase into Rb floxed 
primary myoblasts completely eliminates pRb expression. (A) 
32P 
end-labeled PCR genotype analysis of the floxed Rb locus revealed 
complete excision. Primers flanking the LoxP sites in the Rb locus 
were used to amplify DNA samples from Ad-Lac-Z control– and 
Ad-Cre–infected Rb flox homozygous (f/f) primary myoblasts from 
three independent isolates (Rb
f/f A, Rb
f/f B, and Rb
f/f C). (B) Immuno-
blot detection of pRb from control- and Ad-Cre–infected primary 
myoblast protein extracts indicated a complete absence of pRb. 
Whole cell protein extract was harvested from primary myoblasts in 
growth media (GM) and after 1 d in DM (D1). (C) Immunofluorescent 
staining of control- and Ad-Cre–infected Rb
f/f primary myoblasts. 
Infected primary myoblasts were PFA fixed after 2 d in DM and 
stained with antibody to pRb.870 The Journal of Cell Biology | Volume 166, Number 6, 2004
in wild-type multinucleated myotubes (Fig. 6 C). In con-
trast, the pRb-deficient cells were incapable of completing
the differentiation program, as evidenced by the absence of
multinucleated myotubes expressing MHC (Fig. 6 F). West-
ern blot analysis confirmed the very low level expression of
MHC in Rb
f/f:Ad-Cre–derived cells (Fig. 7 C). Together,
these data suggest that the perinatal death of Rb
f/f:Myf5-Cre
mice is due to an intrinsic defect in differentiation of the
myogenic progenitors.
Pax7 is typically expressed at high levels in proliferating
myoblasts and is rapidly down-regulated upon induction of
differentiation (Seale et al., 2000). Western blot analysis re-
Figure 5. pRb null primary myoblasts exhibit 
high rates of apoptosis in response to serum 
withdrawal. Apoptotic cell death was assessed 
by fluorescein-conjugated TUNEL analysis after 
6 h in DM on control- (A–C) and Ad-Cre–
infected (D–F) Rb
f/f primary myoblasts. Primary 
myoblasts were counterstained with propidium 
iodide (PI).
Figure 6. pRb null primary myoblasts are incapable of forming terminally differentiated multinucleated myotubes. Double immunofluorescent 
staining of control- (A–C) and Ad-Cre–infected (D–F) Rb
f/f primary myoblasts with antibodies to MyoD (FITC) and MHC (rhodamine). Immuno-
fluorescent staining of control- (G–I) and Ad-Cre–infected (J–L) Rb
f/f myoblasts with antibody to myogenin (rhodamine). Nuclei were counter-
stained with DAPI. Infected primary myoblasts were PFA fixed and stained at the indicated time points. GM, growth; DM D1, differentiation 
day 1; DM D5, differentiation day 5.Rb is not required for maintenance of differentiation | Huh et al. 871
vealed that pRb-deficient primary myoblasts exposed to dif-
ferentiation medium fail to down-regulate Pax7 (Fig. 7 C).
Together, these data suggest that the low numbers of surviv-
ing pRb null myoblasts are able to initiate differentiation,
but subsequently fail to properly regulate the progression of
the myogenic program required for the completion of myo-
genic differentiation.
Primary myoblasts lacking pRb fail to arrest upon 
induction of differentiation
To elucidate the cell cycle and differentiation phenotype of
the Ad-Cre–infected Rb
f/f myoblasts, we performed a series
of RNA and protein expression analyses for cell cycle and
differentiation markers. RNA expression levels of cyclins and
cdk’s were analyzed under growth conditions and serum
withdrawal differentiation conditions (n   3). Because of
RNase protection, pRb-deficient primary myoblasts fail to
down-regulate  cyclinA2,  cyclinB1,  cdk1,  cdk2, and cdk4
mRNAs in response to serum withdrawal (Fig. 7, A and B).
Mutant pRb-deficient cells displayed increased levels of
p107 protein under growth conditions in comparison with
the wild-type cells (Fig. 7 C). In addition, postdifferentia-
tion mutant cells continued to express high levels of p107
protein relative to wild-type myotubes (n   3; Fig. 7 C).
However, the levels and pattern of p130 expression appeared
normal (n   3; Fig. 7 C). Therefore, pRb-deficient primary
myoblasts display a similar cell cycle phenotype to that of
MyoD-transfected pRb-deficient fibroblasts (Schneider et
al., 1994; Novitch et al., 1996, 1999).
To investigate whether pRb-deficient myoblasts were ap-
propriately withdrawing from the cell cycle upon induc-
tion of differentiation, we performed BrdU incorporation
experiments on newly differentiated cultures. Wild-type
cells displayed no incorporation of BrdU in cultures ex-
posed for 1 h to BrdU, after 4 d of differentiation (Fig. 8
A). In contrast,  25% of Rb
f/f:Ad-Cre myoblasts present
after a 4-d exposure to differentiation medium incorpo-
rated BrdU (Fig. 8 C). In addition, Rb
f/f:Ad-Cre myocytes
also resumed cell division and exhibited an  50% increase
in total cell numbers after reexposure to growth medium
for 24 h (Fig. 8 D). These data are consistent with the hy-
pothesis that Rb-deficient myoblasts display an intrinsic
Figure 7. Absence of terminal differentiation in pRb null primary 
myoblasts correlates with an inability to down-regulate markers 
of proliferation and early markers of myogenic differentiation. 
(A) RNase protection assay for cyclinA2 and cyclinB1 mRNA in 
control- and Ad-Cre–infected Rb
f/f primary myoblasts. (B) RNase 
protection assay for cdk1, cdk2, and cdk4 mRNA in control- and 
Ad-Cre–infected Rb
f/f myoblasts. GAPDH mRNA levels were used 
as loading controls. Total RNA was harvested from infected myo-
blasts at the indicated time points (A and B). GM, growth; DM 36hr, 
differentiation 36 h. (A and B) White lines indicate that intervening 
lanes have been spliced out. (C) Immunoblot differentiation time 
course analysis of p107, p130, Pax7, MyoD, myogenin, and MHC 
in control- and Ad-Cre–infected Rb
f/f myoblasts.  -Tubulin protein 
levels were used as loading controls. Whole cell protein extract was 
harvested at the indicated time points. GM, growth; D1, differentiation 
day 1; D3, differentiation day 3; D5, differentiation day 5. Protein 
extract from 293T cells was used as a nonmyogenic control.
Figure 8. Serum restimulation is unable to induce DNA synthesis 
in terminally differentiated Rb
f/f:MCK-Cre myotubes. Double 
immunofluorescent staining for BrdU (FITC) and MHC (rhodamine) 
in Rb
f/f:Ad-Lac-Z–infected (A and B), Rb
f/f:Ad-Cre–infected (C and D), 
and Rb
f/f:MCK-Cre (E and F) primary myoblasts. Primary myoblasts 
were cultured in DM for 4 d and were either BrdU pulsed for 1 h 
before fixation (DM D4) or restimulated with BrdU-supplemented 
growth media for 24 h before fixation (DM D4   GM 24 h).872 The Journal of Cell Biology | Volume 166, Number 6, 2004
failure of the G1 restriction point necessary for the switch
to terminal myogenic differentiation.
Primary myoblasts from Rb
f/f:MCK-Cre mice exhibit 
normal differentiation
To investigate whether pRb is required to maintain the ter-
minally differentiated state, we derived primary myoblasts
from Rb
f/f:MCK-Cre mice and examined their growth and
differentiation characteristics. The MCK-Cre transgene has
been used extensively to efficiently and completely excise
floxed alleles in terminally differentiated cardiac and skeletal
muscle (Wang et al., 1999; Zisman et al., 2000; Kim et al.,
2001; Andrechek et al., 2002; Norris et al., 2003). We veri-
fied the efficiency of Rb gene deletion in the Rb
f/f:MCK-Cre
mice by quantitating the allele ratios by 
32P end-labeled PCR
(100% Rb
flox allele present during growth vs.  1% Rb
flox al-
lele remaining by day 5 of differentiation; Fig. 9 A). In addi-
tion, Rb protein levels were undetectable by Western blot
analysis in all three isolates of Rb
f/f:MCK-Cre myoblasts by
day 5 of differentiation (Fig. 9 B). Finally, we did not detect
pRb-positive nuclei in multinucleated MHC-expressing Rb
f/f:
MCK-Cre myotubes by day 5 of differentiation (Fig. 9 C).
Rb
f/f:MCK-Cre primary myoblasts were indistinguishable
from wild-type primary myoblasts in appearance, expression
of myoblast-specific (Pax7 and Myf5) and cell cycle (cyclinA2,
cyclinB1, cdk1, cdk2, and cdk4) regulators, and growth rate
(unpublished data). Importantly, Rb
f/f:MCK-Cre primary myo-
blasts were fully capable of differentiating into robust multi-
nucleated MHC-expressing myotubes that were apparently
normal (n   3 independent isolates; Fig. 9 C).
The levels of pRb over 4 d of differentiation were exam-
ined by Western blot analysis to allow us to determine the
temporal kinetics of pRb elimination by the MCK-Cre trans-
gene (n   3; Fig. 10 B). Levels of pRb in wild-type and mu-
tant cells were similar in growth media and after 2 d in DM
(Fig. 10, compare A with B). However, MCK-Cre–mediated
deletion of the Rb
f/f allele resulted in the complete ablation of
pRb after 4 d of differentiation (Fig. 10, compare A with B).
Figure 9. MCK-Cre transgene efficiently eliminates pRb expression 
in Rb
f/f:MCK-Cre differentiated primary myotubes. (A) 
32P end-
labeled PCR genotype analysis of the floxed Rb locus. Primers 
flanking the LoxP sites in the Rb locus were used to amplify DNA 
samples from Rb
f/f:MCK-Cre primary myoblasts during growth (GM) 
and after 5 d in differentiation conditions (D5) in three independent 
isolates (Rb
f/f:MCK-Cre 1–3). (B) Immunoblot detection of pRb from 
Rb
wt/wt:MCK-Cre control and Rb
f/f:MCK-Cre primary myoblast protein 
extracts.  -Tubulin protein levels were used as loading controls. 
Whole cell protein extract was harvested from primary myoblasts in 
growth media (GM) and after 5 d in DM (D5). (C) Immunofluorescent 
staining of Rb
wt/wt:MCK-Cre control and Rb
f/f:MCK-Cre primary 
myotubes. Myotubes were PFA fixed after 5 d in DM, stained with 
antibodies to pRb (FITC) and MHC (rhodamine), and counterstained 
with DAPI.
Figure 10. Late-stage removal of pRb in differentiated Rb
f/f:MCK-Cre 
myotubes does not result in the up-regulation of p107, MyoD, or 
myogenin protein levels in low serum conditions. (A) Immunoblot 
for pRb in wild-type primary myoblasts. (B) Immunoblot differentiation 
time course analysis of pRb, p107, MyoD, and myogenin in Rb
f/f:
MCK-Cre primary myoblasts. Whole cell protein extract was harvested 
from Rb
f/f:MCK-Cre and wild-type myoblasts at the indicated time 
points. (C) Immunoblot analysis of pRb, p107, MyoD, myogenin, 
cyclin E, and cdk2. Whole cell protein extracts were harvested from 
Rb
f/f:Ad-Lac-Z, Rb
f/f:Ad-Cre, and Rb
f/f:MCK-Cre after 4 d in differ-
entiation media, followed by 24 h in growth media.  -Tubulin protein 
levels were used as loading controls (A–C).Rb is not required for maintenance of differentiation | Huh et al. 873
Interestingly, this late-stage elimination of pRb did not result
in the up-regulation of p107 as observed in Rb
f/f:Ad-Cre cul-
tures (compare Fig. 10 B with Fig. 7 C). Consistent with the
normal differentiation of Rb
f/f:MCK-Cre primary myoblasts,
MyoD and myogenin levels were subject to normal modula-
tion (Fig. 10 B). Thus, functional pRb is critically involved
in the cascade of regulatory events required for progression
through myogenic differentiation, but pRb is not required
for the maintenance of the terminally differentiated state.
Serum stimulation does not induce DNA synthesis 
in Rb
f/f:MCK-Cre myotubes
The presence of pRb has been suggested to be required for
inhibiting de novo DNA synthesis in response to mitogen
restimulation in differentiated myocytes derived from Rb
 / 
teratoma, derived myocytes, and MyoD-transfected fibro-
blasts (Schneider et al., 1994; Novitch et al., 1996). These
experiments suggested that myotubes require pRb for the
suppression of mitogen-activated ectopic S-phases. There-
fore, we investigated the effect of serum stimulation on myo-
tubes lacking pRb that were derived from Rb
f/f:MCK-Cre
primary myoblasts.
Primary myoblasts were cultured in DM for 4 d and either
BrdU pulsed for 1 h before fixation or stimulated with
growth media containing 20% FCS and supplemented with
BrdU for 24 h before fixation (Fig. 8). Our experiments re-
vealed that stimulation of Rb
f/f:MCK-Cre myotubes for 24 h
with growth media did not result in any myotube nuclei en-
tering S-phase, as evidenced by an absence of BrdU incorpo-
ration (Fig. 8 F). Moreover, serum stimulation did not result
in up-regulation of MyoD and cyclin E proteins in Rb
f/f:
MCK-Cre myotubes (Fig. 10 C). However, levels of p107
were reinduced in the Rb
f/f:MCK-Cre myotubes to approxi-
mately half the levels present in the Rb
f/f:Ad-Cre myocytes
(Fig. 10 C). Additionally, higher levels of cyclin E protein
and an activated form of cdk2 were also present in the re-
stimulated  Rb
f/f:Ad-Cre myocytes but not in the Rb
f/f:Ad-
Lac-Z and Rb
f/f:MCK-Cre myotubes (Fig. 10 C). Therefore,
these experiments indicate that pRb is not required to main-
tain the terminally differentiated state in myotubes that are
derived from primary myoblasts.
Discussion
We have used mouse genetics to demonstrate that the comple-
tion of skeletal myogenic differentiation is dependent on pRb
function. The loss of pRb in myogenic precursor cells pre-
cludes their ability to properly couple cell cycle exit with the
progression of differentiation after the induction of myogenin
(Figs. 5–7). Importantly, pRb function was not required for
maintaining the terminally differentiated state of myotubes in
vitro (Figs. 8 and 10) or for the formation of completely differ-
entiated skeletal muscle tissue in vivo (Fig. 3).
Recent studies have demonstrated that many of the devel-
opmental defects observed in the initial Rb knockout studies
were primarily caused by a pRb-dependent extraembryonic
defect in placental development (Wu et al., 2003). Func-
tional rescue of placental defects by the generation of aggre-
gation chimeras with wild-type tetraploid donor embryos re-
sults in Rb
 /  pups that survive to birth without neuronal or
erythroid phenotypes. Notably, the newborn Rb
 /  pups ex-
hibited ectopic S-phases and apoptosis in the lens, together
with extensive deficiencies in skeletal muscle differentiation
(de Bruin et al., 2003). The muscle phenotype in these ani-
mals is strikingly reminiscent of the Rb
f/f:Myf5-Cre muscle
phenotype. Importantly, our experiments provide the formal
genetic proof that pRb is required in a cell-autonomous
manner for skeletal muscle development.
Ad-Cre–infected Rb
f/f primary myoblasts could not prop-
erly form multinucleated MHC-expressing myotubes (Fig.
6). Additionally, Rb
f/f:Ad-Cre myoblasts were unable to
down-regulate cyclins, cdk’s, p107, Pax7, MyoD, and myoge-
nin when withdrawn from serum (Fig. 7). However, upon
induction of differentiation, Rb
f/f:Ad-Cre myoblasts up-reg-
ulated myogenin expression, which is an immediate early
marker of commitment for differentiation (Bergstrom et al.,
2002). Therefore, we conclude that Rb
f/f:Ad-Cre myoblasts
enter the differentiation program but fail to progress, as evi-
denced by continued Pax7 expression, cell division, and fail-
ure to form multinucleated myotubes.
Activation of myogenin transcription is directly mediated
by MyoD binding to E-boxes located in the proximal myo-
genin promoter in response to differentiation-inducing sig-
nals (Gerber et al., 1997; Bergstrom et al., 2002). Therefore,
these data are consistent with the suggestion that myogenin
induction occurs independently of Rb transcriptional induc-
tion during myogenic differentiation.
During muscle differentiation, pRb becomes hypophos-
phorylated and mRNA and protein levels increase  10-fold
(Martelli et al., 1994; Corbeil et al., 1995). MyoD activa-
tion during differentiation is responsible for the transcrip-
tional activation of the Rb (Martelli et al., 1994). More
recent studies demonstrate that MyoD activation of Rb tran-
scription requires a cyclic AMP–responsive element in the
Rb promoter, which binds CREB protein (Magenta et al.,
2003). Moreover, CREB is phosphorylated during myo-
genic differentiation and recruits MyoD, p300, and pCAF
to the Rb promoter (Magenta et al., 2003). Therefore, both
Rb and myogenin are immediate early targets of MyoD-
mediated transcriptional activation during the switch to
myogenic differentiation. Our experiments demonstrate that
pRb activity is absolutely required for MyoD-mediated cell
cycle exit and completion of the differentiation program,
but not for activation of myogenin.
The severe myogenic differentiation defect seen in the
Rb
f/f:Myf5-Cre mice (Figs. 1 and 2) and the Rb
f/f:Ad-Cre pri-
mary myoblasts (Figs. 5–7) was in stark contrast with the
normal phenotype observed in the Rb
f/f:MCK-Cre skeletal
muscle from which pRb was eliminated after the completion
of differentiation (Figs. 3 and 9). Furthermore, primary myo-
blasts isolated from Rb
f/f:MCK-Cre mice were also able to
properly differentiate into multinucleated MHC-positive
myotubes. The Rb
f/f:MCK-Cre myotubes lacking pRb did
not incorporate BrdU when restimulated with growth media
for 24 h (Fig. 8 F). However, Rb
f/f:Ad-Cre myocytes were
fully capable of incorporating BrdU and resuming cell divi-
sion upon growth media restimulation (Fig. 8 D). The per-
sistence of activated cdk2 (Fig. 10 C) and an abundance of
its regulatory subunit cyclin E (Fig. 10 C) observed in the
restimulated Rb
f/f:Ad-Cre myocytes, but not in the Rb
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Lac-Z and Rb
f/f:MCK-Cre myotubes, are indicative of the ac-
tively proliferating state of the restimulated Rb
f/f:Ad-Cre myo-
cytes (Cenciarelli et al., 1999). Interestingly, serum restim-
ulation of Rb
f/f:MCK-Cre myotubes results in the induction
of p107 protein (Fig. 10 C). However, despite the induction
of p107 in differentiated myotubes, the cell cycle continues
to be checked. Up-regulation of cell cycle genes has previ-
ously been reported in serum-treated terminally differenti-
ated C2C12 myotubes. Serum restimulation of C2C12 myo-
tubes induces immediate early genes such as c-fos, c-jun, c-myc,
and Id-1 (Tiainen et al., 1996a). Moreover, cell cycle genes
such as cyclin D1 and cdc2 were similarly serum-induced to
levels comparable to that of proliferation (Jahn et al., 1994),
yet no evidence of cell cycle reentry was ever observed.
Therefore, Rb
f/f:MCK-Cre myotubes are capable of inhibit-
ing DNA synthesis and maintaining the terminally differen-
tiated state in the absence of pRb.
The maintenance of the terminally differentiated state is
likely the effect of multiple mechanisms that may include
p130–E2F4 complexes (Corbeil et al., 1995; Takahashi et
al., 2000), cyclin D3 complexes (Cenciarelli et al., 1999),
p21 activity (Jiang et al., 2000; Mal et al., 2000), and inhibi-
tion of cyclin D1 expression (Skapek et al., 1995; Latella et
al., 2001). Notably, forced expression of E2F1 in differenti-
ated C2C12 myotubes is insufficient to induce ectopic
DNA synthesis (Tiainen et al., 1996a). However, the expres-
sion of viral oncoproteins such as E1A (Tiainen et al.,
1996b) and SV40 large T antigen (Gu et al., 1993) in
C2C12 myotubes can induce ectopic DNA synthesis, but
these oncoproteins are both known to inactivate multiple
checkpoint mechanisms (Helt and Galloway, 2003). There-
fore, terminal differentiation is a very stable state that ap-
pears tolerant of inactivation of single pathways.
A high proportion of pRb-deficient myoblasts undergo
apoptosis in response to induction of differentiation. Inter-
estingly, attenuation of N-ras signaling has been suggested
to rescue this apoptotic response of Rb mutant myoblasts
(Takahashi et al., 2003). The set of genes activated by mito-
gens via the Ras–MAPK pathway are very similar to the
genes activated after E2F induction (Muller et al., 2001).
Moreover, forced expression of E2Fs results in high rates of
apoptosis (Stevaux and Dyson, 2002), and elevated rates of
apoptosis in the cortex of Rb
 /  embryos are attenuated by
crossing into E2F1 and E2F3 mutant backgrounds (Ziebold
et al., 2001). Several proapoptotic genes including caspase 3
have been suggested to represent E2F target genes (Muller et
al., 2001). Notably, caspase 3 is up-regulated upon myogenic
differentiation and is required for normal progression of the
differentiation program (Fernando et al., 2002). Therefore,
it is interesting to speculate that pRb may play a protective
role in preventing an apoptotic response to activated caspase
3 during myogenic differentiation.
In this paper, we have demonstrated that pRb is essential
for progression to terminal myogenic differentiation. Several
pRb-dependent mechanisms have been suggested to play
important roles in the regulation of myogenesis. Dominant
negative N-ras enhances MyoD-mediated expression from
an MCK reporter construct in Rb
 /  fibroblasts (Lee et al.,
1999). Additionally, N-ras
 / :Rb
 /  compound mutant mus-
cle appears to be relatively normal, suggesting that N-ras
plays a role in mediating the defect in differentiation of
pRb-deficient myoblasts (Takahashi et al., 2003). Other
studies have suggested that dynamic interactions between
pRb, HDAC1, and MyoD play an important role (Puri et
al., 2001). Alternatively, pRb inhibition of Id2 has been sug-
gested to potentiate MyoD activity (Lasorella et al., 2000).
Clearly, the importance of these interactions must be reas-
sessed under a unified context in light of our findings.
We have demonstrated that pRb is required during the
early stages of differentiation in order to properly control cell
cycle exit and regulate the progression of the differentiation
program. However, maintenance of myogenic terminal differ-
entiation does not require pRb. Identifying the early pRb-
dependent downstream regulatory network could potentially
be valuable in developing highly efficient stem cell therapeutics
for a broad range of myopathies. Future studies will address the
mechanisms and the downstream targets of pRb regulation dur-
ing the early stages of skeletal muscle differentiation.
Materials and methods
Mice and cell culture
Mice carrying the LoxP-targeted Rb allele (Rb floxed; provided by M. Vooijs
and A. Berns, Netherlands Cancer Institute, Amsterdam, Netherlands;
Marino et al., 2000) were backcrossed into the BALB/cJ and FVB strains and
bred with either Myf5-Cre mice (provided by P. Soriano, Fred Hutchinson
Cancer Research Center, Seattle, WA; Tallquist et al., 2000) or transgenic
MCK-Cre mice (provided by R. Kahn, Joslin Diabetes Center, Boston, MA;
Wang et al., 1999). Primary myoblasts were derived from lower hind limb
skeletal muscle of 4–8-wk-old mice as described previously (Sabourin et al.,
1999). All primary myoblast isolations were expanded and enriched to
 99% purity (assessed by desmin and MyoD staining) before experimental
use. Primary myoblasts were differentiated in 5% horse serum in DME for
the duration of time indicated in the figure legends. Rb
f/f:MCK-Cre myo-
blasts were differentiated for 3 d in 5% horse serum, followed by 2 d in 5%
horse serum in DME supplemented with 5 mg/ml cytosine arabinoside. Cy-
tosine arabinoside was used to eliminate dividing mononuclear cells in cul-
ture. For adenoviral infections of primary myoblasts, 300,000 cells per
60-mm dish were seeded and infected with Ad-Cre or Ad-Lac-Z at 5 multi-
plicity of infection for 1 h using established techniques (Parks et al., 1999).
To assess the efficiency of Cre-mediated excision, genomic DNA was iso-
lated from Ad-Cre–infected myoblasts and was PCR genotyped using prim-
ers that flank the LoxP-targeted Rb locus (Marino et al., 2000).
Single fiber isolation
A single-fiber isolation procedure was performed on the extensor digitorum
longus muscle of 8-wk-old Rb
f/f:MCK-Cre and Rb
f/wt control littermates as
described previously (Rosenblatt et al., 1995). 20 fibers were lysed in DNA
lysis buffer (100 mM Tris-HCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM
NaCl, and 100  g/ml proteinase K), and the DNA was precipitated by iso-
propanol and washed once in 70% ethanol. 200 fibers were lysed in pro-
tein extraction buffer (50 mM Tris-HCl, pH 7.4, 0.1% Triton X-100, 5 mM
EDTA, 250 mM NaCl, and 50 mM NaF) supplemented with protease inhib-
itors (0.1 mM Na3VO4, 1 mM PMSF, and 10  g/ml leupeptin).
32P End-labeled PCR and densitometry analysis
Rb flox forward primer was end labeled with  -[
32P]ATP (Amersham Bio-
sciences) by T4 kinase (Invitrogen) in a final reaction volume of 20  l. Rb
flox PCR was performed under standard conditions using 0.4  l of end-
labeled primer in each 10- l PCR reaction. 20 ng DNA was used as a start-
ing template in each PCR reaction. Radiolabeled PCR products were re-
solved on a 7% denaturing acrylamide gel and exposed on film. Band
densities were quantified using ImageJ analysis software. Rb
flox:Rb
excised al-
lele ratios were determined by densitometry analysis, and an allele ratio
standard curve was constructed. Sensitivity of detection was determined
by decreasing the total ratio of Rb
flox DNA to Rb
excised DNA in 10-fold steps.
BrdU-pulsed cell cycle analysis
Exponentially growing asynchronous Ad-Cre– and Ad-Lac-Z–infected Rb
f/f
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30  M. Myoblasts were trypsinized, pelleted, and washed twice in ice-
cold PBS. Myoblasts were stained for BrdU incorporation and total DNA
content using the BrdU Flow Kit (BD Biosciences) according to the manu-
facturer’s instructions. Flow cytometry was performed on a FACStar (Beck-
man Coulter).
TUNEL assay
Ad-Cre– and Ad-Lac-Z–infected Rb
f/f myoblasts were grown on collagen-
coated 4-well poly-L-lysine chamber slides (Lab-Tek). Cells were fixed with
4% formaldehyde in PBS at the 6-h differentiation time point. TUNEL as-
says were performed using the ApoAlert DNA Fragmentation Kit (CLON-
TECH Laboratories, Inc.) according to the manufacturer’s instructions.
TUNEL staining was analyzed and photographed on an Axioskop micro-
scope (Carl Zeiss MicroImaging, Inc.) equipped with a UV source and
FITC, rhodamine, and HOECHST detection filters.
RNase protection and Western analysis
Total RNA was extracted from Ad-Cre and Ad-Lac-Z Rb
f/f primary myo-
blasts using the RNeasy Mini-Kit (QIAGEN). RNase protection assay was
performed using the RiboQuant kit along with the multi-probe template
sets m-CYC-1 and m-CC-1 (BD Biosciences). 2  g of total RNA from each
time point was used for the ribo-probe hybridization incubation. The
RNase protection assay was completed according to the manufacturer’s
instructions.
Primary myoblasts were harvested and lysed in RIPA extraction buffer
(50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate, 5 mM EDTA, 150 mM NaCl, and 50 mM NaF)
supplemented with protease inhibitors (complete; Roche) on ice. Western
blots were probed with the following antibodies: to pRb, 1:1,000 (41302;
BD Biosciences); to p107, 1:500 (c-18; Santa Cruz Biotechnology, Inc.); to
p130, 1:2,000 (ab6545-100; Ab-Cam); to Pax7, 1:10 (Developmental
Studies Hybridoma Bank [DSHB]); to myogenin, 1:10 (F5D; DSHB); to
MyoD, 1:1,000 (c-20; Santa Cruz Biotechnology, Inc.); to MHC, 1:10 (MF-
20; DSHB); to cyclin E, 1:1,000 (06-459; Upstate Biotechnology); to cdk2,
1:1,000 (M2; Santa Cruz Biotechnology, Inc.); and to  -tubulin, 1:3,500 (T
9026; Sigma-Aldrich). Secondary detection was performed with HRP-con-
jugated antibodies (Bio-Rad Laboratories). Membrane-bound immune
complexes were visualized by ECL Plus kit (Amersham Biosciences).
Immunostaining
Tissue samples were fixed in 4% PFA at 4 C overnight. Samples were
washed in PBS for 30 min and processed for paraffin embedding. Sections
were dewaxed in two washes of Citri-Solv for 5 min each and rehydrated
in graded alcohol washes. Antigen retrieval was performed by immersing
sections in boiling citrate buffer (0.21% wt/vol citric acid monohydrate in
dH2O) for 10 min with continuous agitation. Slides were allowed to cool
down to room temperature and transferred into PBS. Sections were stained
with antibodies to desmin (1:200, clone D33; DakoCytomation) and to
MHC (1:10, MF-20) using the fluorescent MOM kit (Vector Laboratories).
Primary myoblasts were grown on collagen-coated 4-well poly-L-lysine
chamber slides (Lab-Tek). Cells were fixed with 2% PFA and permeabi-
lized with 0.2% Triton X-100. Cells were stained with the following anti-
bodies: to MyoD, 1:200 (M-318; Santa Cruz Biotechnology, Inc.); to MHC,
1:10 (MF-20); to myogenin, 1:10 (F5D); and to pRb, 1:250 (41302). Sec-
ondary detection was performed with fluorescein- or rhodamine-conju-
gated antibodies (CHEMICON International, Inc.). Cells were counter-
stained with DAPI and mounted in aqueous fluorescent mounting media
(DakoCytomation). Bright-field, phase, and fluorescent images were viewed
using an Axioplan2 fluorescent microscope (Carl Zeiss MicroImaging, Inc.)
and digitally acquired (Axiocam or Axiovision 3.1; Carl Zeiss MicroImag-
ing, Inc.) at room temperature. Image-processing software (Photoshop 7;
Adobe) was used to overlay images and enhance color and clarity. Images
were viewed through air-objective lenses (40 /0.75; 20 /0.5; 5 /0.12
[Carl Zeiss MicroImaging, Inc.]).
DNA synthesis assay
Primary myoblasts were grown on collagen-coated 4-well poly-L-lysine
chamber slides. Cells were induced to differentiate in DM for 4 d. Before
fixation, cells were pulsed with 30  M BrdU for 1 h or restimulated in
growth media supplemented with 30  M BrdU for 24 h. Fixed cells were
processed for BrdU staining using the BrdU in situ staining kit (BD Bio-
sciences) according to the manufacturer’s instructions. The final HRP-
streptavidin incubation was omitted and replaced with fluorescein-conju-
gated streptavidin (1:200; Vector Laboratories). Cells were washed twice in
PBS and double stained using rabbit antimyosin skeletal muscle (1:500,
M7523; Sigma-Aldrich). Anti–rabbit rhodamine-conjugated secondary an-
tibody was used to detect the myosin antibody.
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